BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Bluebird CMO Set to Depart as Company Faces Uncertainty with Split, SCD Treatment

  Another bluebird bio executive is jumping ship. Chief Medical Officer David Davidson is leaving the company on April 16.

  March 17, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Deals

  FTC Joins Multinational Group to Crack Down on Biopharma Mergers

  The goal is to “identify concrete and actionable steps to review and update the analysis of pharmaceutical mergers.”

  March 17, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Sponsored | Employing Immunologic Testing to Expedite Detection and Control the Spread of COVID-19

  To support the development of immunodiagnostic assay, Sino Biological has successfully generated biologically active and stable Spike and NP proteins of SARS-CoV-2.

  March 17, 2021

   · 

  2 min read
• 

  Business

  Get to Know Sanjeev Luther, CEO and Board Member of Rafael Pharmaceuticals

  BioSpace recently spoke with Sanjeev Luther, CEO and board member of Rafael Pharmaceuticals, a clinical-late stage metabolic therapeutics company.

  March 17, 2021

   · 

  3 min read

   · 

  Gina Hagler
• 

  Business

  Oxford Spinout Vaccitech Raises $168 Million in Series B Financing Round

  Infectious disease-focused Vaccitech, which partnered with AstraZeneca and Oxford University on the development and manufacturing of that company’s COVID-19 vaccine, raised $168 million in a Series B financing round.

  March 17, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Business

  Merck Enters Into New Collab to Advance Neurodegenerative Candidates With Amathus

  Amathus Therapeutics, a biopharmaceutical company working on small molecule modulators across diverse genetically defined diseases, has entered into a strategic collaboration with Merck to develop novel small molecule treatment candidates for neurodegenerative diseases.

  March 17, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Pharm Country

  Ocugen to Seek EUA for India-Developed COVID-19 Vaccine in the United States

  Pennsylvania-based Ocugen has struck a deal to sell 100 million doses of a COVID-19 vaccine India’s Bharat Biotech in the United States later this year.

  March 17, 2021

   · 

  2 min read

   · 

  Alex Keown
• 

  Career Advice

  Should You Change Careers During the Pandemic?

  Here are four questions to think about when considering a career change during the pandemic.

  March 17, 2021

   · 

  3 min read

   · 

  Porschia Parker-Griffin
• 

  BioSpace Global Roundup: Antiverse Scores $2 Million to Advance AI Antibody Program

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

  March 17, 2021

   · 

  7 min read

   · 

  Alex Keown
• 

  Policy

  AstraZeneca Troubles Continue as Study Shows Ineffectiveness Against South African Variant

  France and Germany are two out of more than a dozen countries that suspended deployment of the AstraZeneca-Oxford University vaccine after reports of blood clots were reported.

  March 17, 2021

   · 

  4 min read

   · 

  Mark Terry